Antigenic characterization of medullary carcinoma of the breast: HLA-DR expression in lymph node positive cases

Applied Immunohistochemistry and Molecular Morphology

Volumn 9, Issue 3, 2001, Pages 234-241

  Lazzaro, B ^a   Anderson, A E ^a   Kajdacsy Balla, A ^a   Hessner, M J ^a  

^a NONE   (United States)

Author keywords

Ductal carcinoma; HLA DR; Immunohistochemistry; Medullary breast carcinoma; MHC class II; PCR; TIL

Indexed keywords

HLA DR ANTIGEN; PEANUT AGGLUTININ; PEROXIDASE;

ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MEDULLARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STAINING;

BREAST NEOPLASMS; CARCINOMA, MEDULLARY; HLA-DR ANTIGENS; HUMANS; LYMPHATIC METASTASIS; POLYMERASE CHAIN REACTION;

EID: 0034856964     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-200109000-00007     Document Type: Article

References (29)

1. Medullary carcinoma
2. Medullary carcinoma of the breast: A clinicopathologic study with appraisal of current diagnostic criteria
3. Medullary carcinoma of the breast. Prevalence and importance of classical risk factors in breast cancer
4. A ten year study of medullary carcinoma of the breast
5. Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells
6. Frequent expression of HLA-DR antigen in medullary carcinoma of the breast
7. Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance
8. High endothelial venule and immunocompetent cells in typical medullary carcinoma of the breast
9. Antigenic phenotype of the lymphocytic component of medullary carcinoma of the breast
10. Cytotoxicity of histocompatibility leukocyte antigen-DR8-restricted CD4 killer T cells against human autologous squamous cell carcinoma
11. A new categorization of HLA-DR alleles on a functional basis
12. Class II-transfected tumor cells directly present endogenous antigen to CD 4+ T cells in vitro and are APC's for tumor-encoded antigens in vivo
13. CD4+ T lymphocytes infiltrating human breast cancer recognize autologous tumor in an MHC-class-II restricted fashion
14. Pocket 4 of the HLA-DR (alpha, beta 1*0401) molecule is a major determinant of T cells' recognition of peptide
15. Selective apoptosis of neoplastic cells by the HLA-DR-specific monoclonal antibody
16. Medullary carcinoma of the breast: A clinicopathologic study with 10 year follow-up
17. Prognostic comparison of three classifications for medullary carcinomas of the breast
18. Comparative study of two methods of HLA-DR typing: Serology and PCR/Dot Blot Reverse
19. Comparison of methods for extracting DNA from formalin-fixed paraffin sections for nonisotopic PCR
20. Sequence-based typing of HLA class II DR B1, B3, B4, and B5
21. Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast
22. Medullary carcinoma of the breast: An association with negative hormonal receptors
23. Medullary breast carcinoma vs. poorly differentiated ductal carcinoma: An immunohistochemical study with keratin 19 and oestrogen receptor staining
24. DNA ploidy and S-phase fraction in medullary carcinoma of the breast - A flow cytometric analysis using archival material
25. Comparison of DNA content, S-phase fraction, and survival between medullary and ductal carcinoma of the breast
26. Prognostic significance of T-cell infiltrates, expression of beta-2-microglobulin and HLA-DR antigens in breast carcinoma
27. An evaluation of the prognostic significance of HLA-DR expression in axillary nodenegative breast cancer
28. Different patterns of HLA-DR antigen expression in normal epithelium, hyperplastic and neoplastic malignant lesions of the breast